Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-024444
Filing Date
2025-09-12
Accepted
2025-09-12 18:25:09
Documents
1
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 form4-09122025_060905.html 4  
1 form4-09122025_060905.xml 4 13838
  Complete submission text file 0001415889-25-024444.txt   15331
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LB PHARMACEUTICALS INC 575 MADISON AVENUE NEW YORK NY 10022
Business Address
Eramo Anna (Reporting) CIK: 0002030921 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42831 | Film No.: 251312691